354 related articles for article (PubMed ID: 32131606)
21. Influence of functional food components on gut health.
Wan MLY; Ling KH; El-Nezami H; Wang MF
Crit Rev Food Sci Nutr; 2019; 59(12):1927-1936. PubMed ID: 29381385
[TBL] [Abstract][Full Text] [Related]
22. Gut microbiota in kidney disease and hypertension.
Antza C; Stabouli S; Kotsis V
Pharmacol Res; 2018 Apr; 130():198-203. PubMed ID: 29496593
[TBL] [Abstract][Full Text] [Related]
23. The microbiome of the critically ill patient.
Akrami K; Sweeney DA
Curr Opin Crit Care; 2018 Feb; 24(1):49-54. PubMed ID: 29257783
[TBL] [Abstract][Full Text] [Related]
24. Probiotic supplementation in children with cystic fibrosis-a systematic review.
Ananthan A; Balasubramanian H; Rao S; Patole S
Eur J Pediatr; 2016 Oct; 175(10):1255-66. PubMed ID: 27576473
[TBL] [Abstract][Full Text] [Related]
25. Acute Kidney Injury and Gut Dysbiosis: A Narrative Review Focus on Pathophysiology and Treatment.
Chou YT; Kan WC; Shiao CC
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409017
[TBL] [Abstract][Full Text] [Related]
26. Microbiota and Food Allergy.
Shu SA; Yuen AWT; Woo E; Chu KH; Kwan HS; Yang GX; Yang Y; Leung PSC
Clin Rev Allergy Immunol; 2019 Aug; 57(1):83-97. PubMed ID: 30564985
[TBL] [Abstract][Full Text] [Related]
27. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment.
Koszewicz M; Jaroch J; Brzecka A; Ejma M; Budrewicz S; Mikhaleva LM; Muresanu C; Schield P; Somasundaram SG; Kirkland CE; Avila-Rodriguez M; Aliev G
Pharmacol Res; 2021 Feb; 164():105277. PubMed ID: 33166735
[TBL] [Abstract][Full Text] [Related]
28. Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics.
Cho MS; Kim SY; Suk KT; Kim BY
J Microbiol; 2018 Dec; 56(12):855-867. PubMed ID: 30377993
[TBL] [Abstract][Full Text] [Related]
29. Gut Microbiota and Obesity: A Role for Probiotics.
Abenavoli L; Scarpellini E; Colica C; Boccuto L; Salehi B; Sharifi-Rad J; Aiello V; Romano B; De Lorenzo A; Izzo AA; Capasso R
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31703257
[TBL] [Abstract][Full Text] [Related]
30. The Importance of the Microbiome in Critically Ill Patients: Role of Nutrition.
Moron R; Galvez J; Colmenero M; Anderson P; Cabeza J; Rodriguez-Cabezas ME
Nutrients; 2019 Dec; 11(12):. PubMed ID: 31817895
[TBL] [Abstract][Full Text] [Related]
31. The potential impact of gut microbiota on your health:Current status and future challenges.
Sirisinha S
Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
[TBL] [Abstract][Full Text] [Related]
32. Skin dysbiosis and loss of microbiome site specificity in critically ill patients.
Klassert TE; Zubiria-Barrera C; Denkel L; Neubert R; Schneegans A; Kulle A; Vester A; Bloos F; Schulze C; Epstude J; Gastmeier P; Geffers C; Slevogt H
Microbiol Spectr; 2024 Mar; 12(3):e0307823. PubMed ID: 38353551
[TBL] [Abstract][Full Text] [Related]
33. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
[TBL] [Abstract][Full Text] [Related]
34. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
Suk KT; Kim DJ
Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
[TBL] [Abstract][Full Text] [Related]
35. Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis.
Manzanares W; Lemieux M; Langlois PL; Wischmeyer PE
Crit Care; 2016 Aug; 19():262. PubMed ID: 27538711
[TBL] [Abstract][Full Text] [Related]
36. Dysbiosis in Functional Bowel Disorders.
Enck P; Mazurak N
Ann Nutr Metab; 2018; 72(4):296-306. PubMed ID: 29694952
[TBL] [Abstract][Full Text] [Related]
37. Fecal Microbiota Transplantation for the Critically Ill Patient.
Limketkai BN; Hendler S; Ting PS; Parian AM
Nutr Clin Pract; 2019 Feb; 34(1):73-79. PubMed ID: 30561131
[TBL] [Abstract][Full Text] [Related]
38. Gut Microbiota and Cardiovascular Diseases: A Critical Review.
Anselmi G; Gagliardi L; Egidi G; Leone S; Gasbarrini A; Miggiano GAD; Galiuto L
Cardiol Rev; 2021 Jul-Aug 01; 29(4):195-204. PubMed ID: 32639240
[TBL] [Abstract][Full Text] [Related]
39. METABOLIC DYSBIOSIS OF THE GUT MICROBIOTA AND ITS BIOMARKERS.
Sitkin SI; Tkachenko EI; Vakhitov TY
Eksp Klin Gastroenterol; 2016 Jul; 12(12):6-29. PubMed ID: 29889418
[TBL] [Abstract][Full Text] [Related]
40. Meta-analysis of alcohol induced gut dysbiosis and the resulting behavioral impact.
Qamar N; Castano D; Patt C; Chu T; Cottrell J; Chang SL
Behav Brain Res; 2019 Dec; 376():112196. PubMed ID: 31476330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
